FOXO4-DRI

Be the first to review

$99.99

Senolytic peptide researched for cellular-senescence clearance studies.

Analytical Reports

Verify a batch →

✓Lot HLX-036-A99.5%COA

SenolyticLongevityCellular Aging

Size

Bulk pricing — save up to 32%

$99.99

COA includedFree ship $200+70 in stock

About FOXO4-DRI

FOXO4-DRI is a synthetic peptide studied for its senolytic activity — disrupting the FOXO4-p53 interaction to selectively target senescent cells in cellular-aging research.

For research use only. This product is intended strictly for laboratory research and is not for human or veterinary use. It is not a drug, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease.

SPECIFICATIONS

Purity: ≥ 99%

CURRENT BATCH

VERIFIED

Lot #: HLX-036-A
Tested Purity: 99.5%
Best By: 10/2028

View Certificate of Analysis

QUALITY STANDARDS

Greater than 99% purity
LPS / endotoxins screened
Heavy metals tested
Sterility guaranteed

SOURCING STANDARDS

Raw ingredients from an FDA-registered, cGMP-audited supplier.
Finished peptides 0.22µm sterile-filtered and aseptically produced in a GMP facility.
Tested by a US FDA-registered, ISO/IEC-accredited third-party analytical lab.

Money-Back Guarantee

Satisfaction Guarantee

Easy Returns

Secure Ordering

HEALIX vs THE COMPETITION

	Healix	Typical Competitor
Pricing	✓ Competitive	✕ Often overpriced
Testing	✓ Third-party verified COAs	✕ No testing or first-party only
Batch transparency	✓ Public COA lookup	✕ None
Shipping	✓ Same / next-day	✕ Varies

Always quality-tested, verified with third-party COAs

Every batch is screened across four characteristics — identity, purity, sterility, and endotoxicity — with an independent Certificate of Analysis to verify each result.

Identity

Confirmed by mass spectrometry

Purity

Quantified by reverse-phase HPLC

Sterility

0.22µm sterile-filtered, aseptic fill

Endotoxicity

LPS / endotoxin screened